News
OSRH
0.5510
+0.81%
0.0044
OSR Holdings COO Yeiseok Kim files initial beneficial ownership statement
PUBT · 20h ago
South Korea's best-rated stocks: From financials to semiconductors, ranked by Quant scores
Seeking Alpha · 1d ago
Weekly Report: what happened at OSRH last week (0406-0410)?
Weekly Report · 4d ago
OSR Holdings Amends Equity Line, Secures Convertible Note
TipRanks · 04/09 14:22
OSR Holdings eliminates $2.02M warrant overhang
TipRanks · 04/09 13:34
OSR Holdings Eliminates $2.02M Warrant Overhang; Issues $555K Convertible Note At $1 Premium Share Price
Benzinga · 04/09 13:17
OSR Holdings issues $1.06 million convertible note to retire $2.02 million warrants
Reuters · 04/09 13:16
Weekly Report: what happened at OSRH last week (0330-0403)?
Weekly Report · 04/06 10:19
OSR Holdings amends 8-K, corrects VXM01 license agreement exhibit share price
Reuters · 04/03 10:15
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 04/02 21:05
OSR Holdings Revises Global License Deal for VXM01
TipRanks · 04/02 20:19
OSR Holdings Signs Revised Global Licensing Deal For VXM01; BCME To Pay Up To $815M In Milestone Payments To OSR Holdings; To Provide Vaximm With Up To $30M Development Financing Facility
Benzinga · 04/02 19:54
OSR HOLDINGS INC - TO PROVIDE VAXIMM WITH UP TO $30 MLN DEVELOPMENT FINANCING FACILITY - SEC FILING
Reuters · 04/02 19:48
OSR Holdings signs term sheet for VXM01 license with up to $815 million milestones
Reuters · 04/02 19:46
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 04/01 21:05
OSR Holdings Q4 EPS $(0.16) Misses $(0.10) Estimate, Sales $381.269K Miss $761.000K Estimate
Benzinga · 03/31 22:45
OSR Holdings FY25 operating loss widens 57% to $18.3 million; net sales fall 18% to $2.9 million
Reuters · 03/31 20:12
Emerging Growth Research reaffirms OSR Holdings Buy-Emerging, keeps $10 price target
Reuters · 03/30 13:24
OSR Holdings to present investor update at Emerging Growth Conference
Reuters · 03/30 13:04
Weekly Report: what happened at OSRH last week (0323-0327)?
Weekly Report · 03/30 10:19
More
Webull provides a variety of real-time OSRH stock news. You can receive the latest news about OSR Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About OSRH
OSR Holdings, Inc. is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness. Through its subsidiaries, it is engaged in immuno-oncology, regenerative biologics, and medical device technologies. Its operating businesses include developing oral immunotherapies for the treatment of cancer, developing design-augmented (DA) biologics for age-related and other degenerative diseases and neurovascular intervention medical devices and systems distribution in Korea. Its subsidiaries include VAXIMM AG (Vaximm); RMC Co., Ltd. (RMC); Darnatein Co., Ltd. (Darnatein), and Woori IO Co., Ltd. (Woori IO). Vaximm is developing oral immunotherapies for the treatment of cancer and immunological disorders. RMC is a Korea-based neurovascular intervention medical device and systems distribution company. Darnatein is developing DA biologics for age-related and other degenerative diseases. Woori IO is a South Korea-based medical device company.